GH man....Looks like the volume has vanished..Where are all the Dawson guys telling you
that you do not understand this stock..Got to give credit where credit is due...Quay and the boys stole $14 Million. How does that $2.40 stock feel now guys?
#$%$ and #$%$???? You dirt bag! There is a gap at $4.28..technicals says it gets filled then takes off with a very low RSI...Keep your powder dry..
China is in the crapper. South American economies hardly exist. Who is CAT going to sell their machines to? They borrow to buy back stock ala IBM and they lower the employment rolls to make the bottom line. This is not a good sign.
Hey Boogs, do you think they could sell 20 million shares here? They need the capital and I think the sale would go well. What do you think?
The principle is the key as you say. It is external as is the power supply for our device. But vblock is a scope which takes 45 minutes and while invasive is really no harder than my knee scope or my pals pacemaker. But the neuro-stimulation process is getting more attractive. I know of four bariatric surgeries that took hours, months of recuperaiton and still have a load of side effects.
an electrical device for the treatment of migraine headaches...The methodology of using electrical impulse on nerves looks better each dat. I think the device was called cefaly.
This stock mandates you keep an airline barf bag by you laptop! China..could be a tough technical day.
Higher high, filled one gap, and there is one other under the market. If you close at a lower low on volume you get to buy it at $4ish.....
Valu..The only place there is news is in China but it will get here soon enough..I am getting more interested in the use of methanol as an auto fuel as it could really change a lot of the pollution there.
The buying has to be Asian and it will grow...They are on the scene. We should hear about the recent agreement approval by Chinese authorities. Great to see them do $8MM plus in Q1...
JPM may be doing the secondary and is buying the stock to allow the deal?...who knows...Nothing has changed.
Good luck to the folks buying.....I think the secondary is close...
I think the data would be compelling for a big cancer operation like Novartis or maybe Amgen...If SNY bolts the oncology space it makes the playing field smaller and if I had to bet they would finance to take it further themselves..just on the off chance the data is better than disclosed. Prudent management would streamline and focus on 121, 111, 398 and 302. They have a $40 Million loan which has to have some requirements and that shortens the leach even though the aspects of that deal were to me somewhat redacted. But there are a lot of moving parts here. MACK did the 121 trial and it has amazed me they could not forge another deal with the data they had. But this is biotech and it is not easy. But biotech exploded in the last year and MACK did not go along. I will be a sideline looker. They may surprise me but I do not trust Bob Mulroy to deliver. Too many false promises.
You will get a reaction from the approval of the deal they just signed from the Chinese government. I think Yima will be resolved in Q2 to our benefit. The two things that bother me are no progress on the retrofits and the lack of a deal outside China. I think we get a GE deal for one operation with 3 generators in Pakistan sometime this year, but with all the dirty air China stuff in the papers today they are going to move faster than we think. And I do not think they will dilute. Since signing the Zhang deal we will become a full time licensing operation worldwide. Only real money we spend will be on R&D. News will start coming quickly. Hope to see Q1 revenue above $8 Million. One factor a lot miss here. China is going into Africa both feet and in the interior where all the natural resources are located there is scant power sources. Like the Brazilian rain forest they burn trees for everything. Obama and the EPA morons are letting our coal technology get away and Rigdon and the boys fro,m GE will improve the technology now that they have some capital.
This is my best short and long term play.
Sentiment: Strong Buy